These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35543614)

  • 21. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
    Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.
    Roberts JA; Taccone FS; Udy AA; Vincent JL; Jacobs F; Lipman J
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2704-9. PubMed ID: 21402850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
    Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
    Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
    Kimura T; Sunakawa K; Matsuura N; Kubo H; Shimada S; Yago K
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1159-67. PubMed ID: 15047516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Various Estimated Glomerular Filtration Rate Equations on the Pharmacokinetics of Meropenem in Critically Ill Adults.
    Barreto EF; Chang J; Rule AD; Mara KC; Meade LA; Paul J; Jannetto PJ; Athreya AP; Scheetz MH
    Crit Care Explor; 2023 Dec; 5(12):e1011. PubMed ID: 38107538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney function as a key driver of the pharmacokinetic response to high-dose L-carnitine in septic shock.
    Jennaro TS; Puskarich MA; Flott TL; McLellan LA; Jones AE; Pai MP; Stringer KA
    Pharmacotherapy; 2023 Dec; 43(12):1240-1250. PubMed ID: 37775945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers.
    Jing L; Liu TT; Guo Q; Chen M; Lu JJ; Lv CL
    J Clin Pharm Ther; 2020 Feb; 45(1):88-96. PubMed ID: 31463971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
    Hartman SJF; Brüggemann RJ; Orriëns L; Dia N; Schreuder MF; de Wildt SN
    Clin Pharmacokinet; 2020 Feb; 59(2):173-205. PubMed ID: 31432468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
    Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury--true GFR versus urinary creatinine clearance and estimating equations.
    Bragadottir G; Redfors B; Ricksten SE
    Crit Care; 2013 Jun; 17(3):R108. PubMed ID: 23767877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
    Pea F; Furlanut M; Negri C; Pavan F; Crapis M; Cristini F; Viale P
    Antimicrob Agents Chemother; 2009 May; 53(5):1863-7. PubMed ID: 19223642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular filtration rate equations do not accurately predict vancomycin trough concentrations in pediatric patients.
    Alford EL; Chhim RF; Crill CM; Hastings MC; Ault BH; Shelton CM
    Ann Pharmacother; 2014 Jun; 48(6):691-6. PubMed ID: 24646680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
    Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
    Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
    Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
    J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.